Filtered By:
Source: Skin and Allergy News
This page shows you your search results in order of relevance. This is page number 11.
Order by Relevance | Date
Total 905 results found since Jan 2013.
Similarly susceptible skin barriers identified in two types of hand eczema
The skin barriers in patients with allergic/irritant hand eczema (HE) and hyperkeratotic HE had approximately equivalent lipid profiles and susceptibility to sodium lauryl sulfate, according to a study of 23 patients with allergic/irritant HE and 15 patients with hyperkeratotic HE.
However,...
Source: Skin and Allergy News - March 31, 2015 Category: Dermatology Tags: SAN Journals SAN Clinical News SAN News Source Type: news
Supreme Court: Docs cannot sue over low Medicaid payments
Physicians cannot sue state governments over low Medicaid payments, the U.S. Supreme Court ruled.
In a 5-4 decision, the high court overturned a decision by the 9th Circuit Court of Appeals that said physicians and other...
Source: Skin and Allergy News - March 31, 2015 Category: Dermatology Tags: SN Opinions CARD Practice Economics CHEST Practice Economics CEN Practice Economics CNN Practice Economics CPN Practice Economics EM Practice Economics FPN Practice Economics HOSP Practice Economics IMN Practice Economics Source Type: news
Traditional risk factors raise cardiovascular risk in PsA
Psoriatic arthritis is associated with higher rates of self-reported angina pectoris, percutaneous coronary intervention, hypertension, obesity, and smoking than are observed in the general population, a large population-based cohort study found.
However, the overall rate of cardiovascular (CV)...
Source: Skin and Allergy News - April 2, 2015 Category: Dermatology Tags: CME-candidate RHEUM Journal RHEUM News RHEUM Spondyloarthropathies RHEUM Psoriatic arthritis SAN Journals SAN Clinical News Source Type: news
SGR cuts pay by 21%; CMS to hold checks for 2 weeks
Medicare physician pay was cut by approximately 21% effective April 1, due to the expiration of the last temporary fix to the Sustainable Growth Rate formula.
Because legislation to repeal the SGR has passed the House and awaits action in the Senate, the Centers for Medicare & Medicaid...
Source: Skin and Allergy News - April 2, 2015 Category: Dermatology Tags: CARD Practice Economics CHEST Practice Economics CEN Practice Economics CNN Practice Economics CPN Practice Economics EM Practice Economics FPN Practice Economics HOSP Practice Economics IMN Practice Economics OBGYN Practice Economics Source Type: news
No increased risk of lung disease with methotrexate
Methotrexate is not associated with an increased risk of pulmonary disease in patients taking it for the treatment of psoriatic arthritis, psoriasis, or inflammatory bowel disease, a meta-analysis has found.
The analysis of results from seven double-blind, randomized, controlled studies, involving...
Source: Skin and Allergy News - April 2, 2015 Category: Dermatology Tags: CHEST Journals CHEST Clinical News CHEST News CHEST Pulmonary Medicine FPN Journals FPN News FPN Dermatology FPN Gastroenterology Source Type: news
Vaccine pioneer begins reign as acting director of the National Cancer Institute
Dr. Douglas Lowy has been officially named acting director of the National Cancer Institute, following the March 31 exit of Dr. Harold Varmus as director. Dr. Lowy had been serving as the National Cancer Institute’s deputy director since July 2010, according to a <a...
Source: Skin and Allergy News - April 1, 2015 Category: Dermatology Tags: ONCR News ONCR Gynecologic FPN News FPN Oncology IMN Oncology SAN Clinical News SAN News PED News Source Type: news
Weekly adalimumab at 40 mg works best for hidradenitis suppurativa
SAN FRANCISCO – Weekly treatment with 40 mg of adalimumab yielded the strongest clinical responses in adults with moderate to severe hidradenitis suppurativa with a safety profile similar to less intensive doses, according to data from two phase III trials.
Overall, 43% of adalimumab-treated...
Source: Skin and Allergy News - April 1, 2015 Category: Dermatology Tags: SAN Conference News IMN Dermatology IMN News SAN Clinical News SAN News SAN Acne & Rosacea American Academy of Dermatology Source Type: news
Investigational topical sebum inhibitor reduced acne lesions
SAN FRANCISCO – An investigational topical sebum inhibitor met its primary endpoints in a phase IIa trial, significantly reducing inflammatory and noninflammatory lesions in patients with facial acne vulgaris, researchers reported at the annual meeting of the American Academy of Dermatology.
“This...
Source: Skin and Allergy News - April 3, 2015 Category: Dermatology Tags: FPN News FPN Dermatology IMN News IMN Dermatology PED News PED Dermatology SAN Clinical News Source Type: news
IL-23 inhibitor topped ustekinumab against psoriasis
SAN FRANCISCO – An investigational interleukin-23 inhibitor for moderate to severe plaque psoriasis achieved almost twice the PASI 90 response rate of ustekinumab and generated no major safety signals, based on data from randomized trial of...
Source: Skin and Allergy News - April 2, 2015 Category: Dermatology Tags: CME-candidate RHEUM Conference News SAN Clinical News SAN News RHEUM News IMN News IMN Dermatology RHEUM Psoriatic arthritis Source Type: news
Personalized melanoma vaccine evokes immune response
A customized vaccine targeting patient-specific, tumor neoantigens evoked an immune response in three adults with advanced cutaneous melanoma in a proof-of-principle study that paves the way for a phase I trial.
The data are “too premature to conclude that the treatment had any therapeutic benefit...
Source: Skin and Allergy News - April 2, 2015 Category: Dermatology Tags: SAN Journals SAN Clinical News SAN News SAN SCN: Melanoma ONCR Journals ONCR News ONCR Melanoma & Skin Cancers FPN Journals Source Type: news
Avoid voriconazole in transplant patients at risk for skin cancer
SAN FRANCISCO – Voriconazole increased the risk of squamous cell carcinoma by 73% in a review of 455 lung transplant patients at the University of California, San Francisco.
The increase was for any exposure to the drug after transplant (adjusted hazard ratio, 1.73; P = .03). The...
Source: Skin and Allergy News - April 6, 2015 Category: Dermatology Tags: FPN Conferences IMN Conferences SAN Conference News SN Conferences SN News FPN News FPN Dermatology FPN Oncology HOSP News Source Type: news
Medicare is stingy in first year of doctor bonuses
Dr. Michael Kitchell initially welcomed the federal government’s new quality incentives for doctors. His medical group in Iowa has always scored better than most in the quality reports that Medicare has provided doctors in recent years, he said.
But when the government launched a new payment...
Source: Skin and Allergy News - April 6, 2015 Category: Dermatology Tags: CARD Practice Economics CHEST Practice Economics CEN Practice Economics CNN Practice Economics CPN Practice Economics EM Practice Economics FPN Practice Economics HOSP Practice Economics IMN Practice Economics OBGYN Practice Economics Source Type: news
Dermoscopical screening surpasses app for melanoma diagnosis
A smartphone application was less effective at correctly diagnosing malignant melanoma than clinical diagnosis by dermatologists, based on data from a study evaluating 195 melanocytic lesions.
The app, which used fractal image analysis, was 73% specific and 83% sensitive, whereas the...
Source: Skin and Allergy News - April 6, 2015 Category: Dermatology Tags: SAN Journals SAN Clinical News SAN News SAN Actinic Keratosis Source Type: news
TWEAK/Fn14 interactions associated with cutaneous lupus pathogenesis
Interactions between TNF-like weak inducer of apoptosis and its receptor Fn14 are significantly associated with the pathogenesis of cutaneous lupus, according to Dr. Jessica Doerner and her associates.
Treating murine keratinocytes with TWEAK stimulated both RANTES, a T cell important in the...
Source: Skin and Allergy News - April 7, 2015 Category: Dermatology Tags: SAN Journals SAN Clinical News SAN News SAN Atopic Dermatitis RHEUM Journal RHEUM News RHEUM Lupus/Connective Tissue Diseases Source Type: news
Plant-based supplement safely protects against UV radiation
MIAMI BEACH – An oral Polypodium leucotomos extract supplement was safe and effective for sun protection in a randomized, double-blind, placebo-controlled study of 40 participants.
The plant-based supplement, marketed as Heliocare by Ferndale Healthcare, was associated with a significant...
Source: Skin and Allergy News - April 9, 2015 Category: Dermatology Tags: SAN Clinical News SAN News SAN Aesthetic Dermatology Source Type: news
